A New Liver, A New Life Everyday at Medanta !

Medanta’s Technology: the most advanced the world has to offer

World Class Patient Care with a personal touch

Medanta Liver Institute has among the world’s largest and most experienced liver transplant teams of
more than 500 doctors and paramedics

Dr Soin is awarded the Padma Shri in 2010 for pioneering liver transplant in India

Home » Press Clippings » Regulator waived phase three trial to clear COVID-19 drug Itolizumab as India cases continue to rise

Menus

Press Clippings

The New Indian Express

Tuesday, 14, July 2020
"Regulator waived phase three trial to clear COVID-19 drug Itolizumab as India cases continue to rise"

Source : The New Indian Express

Back to Press Clippings

Top

USEFUL LINKS

Dr. A. S. Soin, Chairman

Medanta Institute of Liver Transplantation and Regenerative Medicine, Medanta The Medicity,
Sector 38, Gurgaon,
Haryana 122001, India.